Cargando…

Growth Hormone Therapy for Children With Duchenne Muscular Dystrophy and Glucocorticoid Induced Short Stature

Background: Duchenne Muscular Dystrophy (DMD) is the most common form of inherited muscle disease in childhood. DMD patients have severe growth retardation due to several reasons including chronic treatment with glucocorticoid (GC). Data regarding the efficacy and safety of Recombinant Growth Hormon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavi, Eran, Cohen, Amitay, Dor, Talya, Tsabari, Reuven, Zangen, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090397/ http://dx.doi.org/10.1210/jendso/bvab048.1455

Ejemplares similares

The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy
por: Annexstad, E. J., et al.
Publicado: (2019)

Case Report: The Genetic Diagnosis of Duchenne Muscular Dystrophy in the Middle East
por: Alghamdi, Fouad, et al.
Publicado: (2021)

SUN-LB17 The Association of Growth Hormone Treatment in Children With Short Stature With Idiopathic Scoliosis
por: Nam, Hyo-Kyoung, et al.
Publicado: (2020)

Case Report: Co-occurrence of Duchenne Muscular Dystrophy and Frontometaphyseal Dysplasia 1
por: Kim, Jaewon, et al.
Publicado: (2021)

Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications
por: Mercuri, Eugenio, et al.
Publicado: (2023)

SAT-105 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: El-Naghy, Zeyad, et al.
Publicado: (2020)

PMON331 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: Krasnow, Matthew, et al.
Publicado: (2022)

The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
por: Kansu, Aydan, et al.
Publicado: (2023)

PMON330 The Relationship between Pituitary Volume and Chiari Malformation in Growth Hormone Deficiency and Idiopathic Short Stature
por: Manely, Sarah, et al.
Publicado: (2022)

Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy
por: Kao, Kung-Ting, et al.
Publicado: (2019)

Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review)
por: Zhang, Tianyuan, et al.
Publicado: (2021)

MON-113 The Effect of Body Mass Index on the Peak Growth Hormone Level After Growth Hormone Stimulation Test in Children with Short Stature
por: Lee, Nayeong, et al.
Publicado: (2020)

MON-LB050 Preliminary Results from the "Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy (DMD) (NCT 02571205)"
por: Wood, Claire, et al.
Publicado: (2019)

RF26 | PSAT109 The Prevalence of Abnormalities in Cranial MRIs in Children with Short Stature Prior to Growth Hormone Therapy
por: Epstein, Benjamin, et al.
Publicado: (2022)

Bone Mineral Density Assessment by Quantitative Computed Tomography in Glucocorticoid-Treated Boys With Duchenne Muscular Dystrophy: A Linear Mixed-Effects Modeling Approach
por: Liu, Chuan, et al.
Publicado: (2022)

RF14 | PMON328 The Effect of Pituitary Cysts on Pituitary Volume in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: Patale, Tara, et al.
Publicado: (2022)

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2019)

SAT-LB19 Is There a Need to Use Gadolinium Contrast for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency?
por: Almaghraby, Abdullah, et al.
Publicado: (2020)

SAT-060 Unusual Case of Short Stature and Poor Growth in Childhood
por: Patni, Nivedita, et al.
Publicado: (2020)

Familial Short Stature - a Novel Phenotype of Growth Plate Collagenopathies
por: Plachy, Lukas, et al.
Publicado: (2021)

Consensus Statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia During the Coronavirus Disease 2019 Pandemic
por: Bamaga, Ahmed K., et al.
Publicado: (2021)

Walking alone milestone combined reading-frame rule improves early prediction of Duchenne muscular dystrophy
por: Ma, Yan-li, et al.
Publicado: (2022)

Duchenne Muscular Dystrophy With Low Acidic α-Glucosidase Activity: Two Case Reports and Literature Review
por: He, Xiufang, et al.
Publicado: (2022)

Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia
por: AlSaman, Abdulaziz S., et al.
Publicado: (2022)

SAT-LB17 Triplication of SHOX Downstream Region in Mild Short Stature
por: Bunyan, David J, et al.
Publicado: (2020)

Short stature related to Growth Hormone Insensitivity (GHI) in childhood
por: Mastromauro, Concetta, et al.
Publicado: (2023)

SAT-109 Utilizing Pituitary Volume (PV) and the Growth Hormone Stimulation Test (GHST) to Jointly Define the Etiology of Short Stature (SS): An Improved Diagnostic Criteria for Growth Hormone Treatment
por: Patale, Tara Prasanna, et al.
Publicado: (2020)

PMON193 Reactive oxygen species in the development of gonadal failure in late-onset transaldolase deficiency
por: Zangen, David, et al.
Publicado: (2022)

THU175 Incorrect Age Causing Falsely Short Stature In An Afghan Immigrant Girl
por: Ing, Jordan, et al.
Publicado: (2023)

Cardiac MRI and Echocardiography for Early Diagnosis of Cardiomyopathy Among Boys With Duchenne Muscular Dystrophy: A Cross-Sectional Study
por: Prakash, Nidhi, et al.
Publicado: (2022)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

OR18-5 A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature
por: Boucher, Kimberly, et al.
Publicado: (2022)

OR21-02 Diagnostic Yield Of A Multigene Approach In Children With Short Stature Of Unknown Cause
por: De Andrade, Nathalia Liberatoscioli Menezes, et al.
Publicado: (2023)

PSAT108 Impact of recombinant human growth hormone (rhGH) on skeletal muscle strength, power, endurance and agility in prepubertal boys with significant short stature: preliminary results
por: Welch, Lurah, et al.
Publicado: (2022)

SAT-096 Response to RHGH Therapy in Children with Isolated Short Stature with or Without an Identified Genetic Cause
por: De Andrade, Nathalia Liberatoscioli Menezes, et al.
Publicado: (2020)

Stratifying the Genetic Aetiology in Children Born Small for Gestational Age With Persistent Short Stature (SGA-SS)
por: Toni, Ledjona, et al.
Publicado: (2021)

miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy
por: Sanson, M., et al.
Publicado: (2020)

Positive effect of the combination of multilevel contracture release and glucocorticoid treatment in Duchenne muscular dystrophy
por: Weiß, Claudia, et al.
Publicado: (2020)

Short Stature Diagnosis and Referral
por: Maghnie, Mohamad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_74rqctbcl2m77apr1cn6gcnh1i